Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IM Cannabis Corp C.IMCC

Alternate Symbol(s):  IMCC

IM Cannabis Corp. is a Canada-based medical cannabis company. The Company operates in Israel through its commercial relationship with Focus Medical Herbs Ltd. (Focus Medical), which has a cultivation license to breed, grow and supply medical cannabis products in Israel. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centres and logistical hubs in Israel. The Company operates through Adjupharm GmbH in Europe, which is a medical cannabis producer and distributor with wholesale, narcotics handling, manufacturing, procurement, storage, and distribution licenses granted by German regulatory authorities that allow for import/export capability with requisite permits. The Company operates through Trichome and its subsidiaries Trichome JWC Acquisition Corp. and MYM Nutraceuticals Inc., where it cultivates and processes cannabis for the adult-use market at its Ontario and Nova Scotia facilities under the WAGNERS and Highland Grow brands.


CSE:IMCC - Post by User

Post by LatAmBullon Jun 04, 2020 10:00am
158 Views
Post# 31110936

News - Breaking down the numbers

News - Breaking down the numbersBreaking down the highlights to quantify the implications to financials: 
  • 8,000 kg of product available for sale in 2020, which equates to ~$40 to $48 million in 2020 revenue (at CAD $5 to $6 / gram)
  • 6,000 kg harvest in 2020, which means 75% of 2020 revenue will be grown internally (cash costs <$1 per gram), which should really drive cash flow this year 
  • 11,000 kg of product available for sale in 2021, which equates to ~$55 to $65 million in 2021 revenue (at CAD $5 to $6 / gram)
Please correct me if I'm wrong, but these numbers do not include the German business, which has hit a lot of milestones in the past few weeks, and respresents significant upside over the forecasts presented above. Not to mention they already have multi-million dollar agreements in place in Germany and they are just getting started there. 

IMCC has continued to deliver, keep up the great work!!

https://www.newswire.ca/news-releases/imc-announces-record-harvest-by-focus-medical-and-update-on-israeli-operations-850085769.html
<< Previous
Bullboard Posts
Next >>